To further investigate the potential predictive value of ALCAM expression for chemoradiation in cervical cancer, it will be necessary to investigate ALCAM expression levels in a prospective manner, using i.e. tissue biopsies of patients with advanced disease (FIGO III/IV) to analyse outcome after chemoradiation. Here, ALCAM is linked to cervical carcinoma.